The Safety and Efficacy of Fecal Microbiota Transplantation in the Treatment of Digestive Diseases and Non-digestive System Diseases Associated With Gastrointestinal Symptoms in the Gastrointestinal Tract.

Tongji University

Status: Enrolling

Conditions: Fecal Microbiota Transplantation

Treatments: Procedure: Fecal microbiota transplantation

Study type: Interventional

Funder types: Other

Identifiers

NCT06208930

FMT-ALL

Details and patient eligibility

About

The exploration of the safety and efficacy of fecal microbiota transplantation in the treatment of non-digestive system diseases associated with gastrointestinal symptoms in the gastrointestinal tract, while also investigating the impact of fecal microbiota transplantation on the intestinal system, and assessing the improvement of symptoms in other systems.Simultaneously optimizing the conditions during the FMT process, identifying the most effective treatment methods to enhance the therapeutic outcomes of FMT.

Enrollment: 10,000 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Being able to tolerate a nasoenteric tube or swallow a capsule.

Exclusion criteria

• Intestinal barrier dysfunction. Inability to tolerate enteral nutrition.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Sequential Assignment

Masking: None (Open label)

---

10,000 participants in 1 patient group

FMT group

Experimental group

Treatment:

Procedure: Fecal microbiota transplantation